Révisi nurutkeun 28 April 2020 18.20 édit Muthi'ah Zahra (obrolan \| kontribusi) 1.718 suntingan Tidak ada ringkasan suntingan ← Éditan saméméhna		Révisi nurutkeun 28 April 2020 18.52 édit bolaykeun RaymondSutanto (obrolan \| kontribusi) 214 suntingan mTidak ada ringkasan suntingan Éditan salajengna →
Baris ka-22: \| legal_DE = Rx-only/Anlage III \| legal_status = Rx-only, WHO Recommended Schedule III \| dependency_liability = High~~<ref name=Ait2018/>~~ \| routes_of_administration = [[Oral\|Ngaliwatan biwir]] \| protein_bound = 80% Baris ka-30: \| onset = kurang ti sajam <ref name=Lill2016>{{cite book \|last1=Lilley \|first1=Linda Lane \|last2=Snyder \|first2=Julie S. \|last3=Collins \|first3=Shelly Rainforth \|title=Pharmacology for Canadian Health Care Practice \|date=2016 \|publisher=Elsevier Health Sciences \|isbn=9781771720663 \|page=329 \|url=https://books.google.ca/books?id=dNgoDwAAQBAJ&pg=PA329 }}</ref> \| duration_of_action = 6 hours<ref name=Lill2016/> \| elimination_half-life = Immediate release: 11–13 hours~~<ref name=AHFS2018/>~~<br />Extended release: 11–16 hours~~<ref name=AHFS2018/>~~ \| excretion = [[Ginjal]]

Alprazolam: Béda antarrépisi